The Vanguard Group 13D and 13G filings for FibroGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-07-29 10:34 am Purchase |
2025-06-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 178,040 4.400% |
178,040![]() (New Position) |
Filing |